1,3-Palmitin-2-vaccenoin is a triglyceride.

1,3-Myristin-2-octanoin is a fatty ester.

1,3-Linolenin-2-myristin is an acylglycerol.

1,3-Linolein-2-laurin is an acylglycerol.

1,3-Digamma linolenin is an acylglycerol.

1,3-Butyrin-2-palmitin is an acylglycerol.

1,2-Stearin-3-laurin is an acylglycerol.

1,2-Stearin-3-elaidin is an acylglycerol.

1,2-Palmitolein-3-eicosatrienoin is an acylglycerol.

1,2-Olein-3-butyrin is an acylglycerol.

1,2-Linolenin-3-stearin is an acylglycerol.

1,2-Linolenin-3-olein is an acylglycerol.

1,2-Linolenin-3-myristin is an acylglycerol.

1,2-Linolenin-3-laurin is an acylglycerol.

1,2-Laurin-3-palmitin is an acylglycerol.

1,2-Butyrin-3-stearin is an acylglycerol.

(S,S) Bisoleoyl-lysobisphosphatidic acid is a lysobisphosphatidic acid (LBPA). LBPA plays a role in modulating the cholesterol flux through endosomes.

(S,R,S)-AHPC-Me-amide-C-O-PEG2-COOH is an E3 ligase ligand-linker conjugate. (S,R,S)-AHPC-Me-amide-C-O-PEG2-COOH can be used for synthesis of PROTACs.

(S,R,S)-AHPC-CO-PEG3-NHBoc is a synthesized E3 ligase ligand-linker conjugate that can be used to synthesize PROTAC G9a/GLP degrader 1. PROTAC G9a/GLP degrader 1 is a potent G9a/GLP PROTAC degrader with anti-cancer activity.

(S)-Oxybutynin is a pharmaceutical intermediate. (S)-Oxybutynin can synthesize antifungal agents.

(S)-2-Ketodoxapram ((S)-AHR 5955) is a metabolite of Doxapram. Doxapram is a respiratory stimulant[1][2].

(rel)-Nutlin carboxylic acid is the Nutlin 3-based MDM2 ligand. (rel)-Nutlin carboxylic acid can be connected to the ligand for protein by a linker to form PROTAC.

(Rac)-Azide-deoxy-ascomycin-O-ethylene, a nitrogen-containing compound, is a derivative of a macrolide-type immunosuppressant.

(Rac)-[6]-Gingerol is a natural product. (Rac)-[6]-Gingerol can be isolated from rhizomes of Z. officinale. (Rac)-[6]-Gingerol shows moderate anticancer activity against lung cancer, ovarian cancer, melanoma, and colon cancer.

(R)-SCH-23982 hydrochloride is the R-enantiomer of SCH-23982 hydrochloride. SCH-23982 hydrochloride is a selective dopamine D1 receptor antagonist. (R)-SCH-23982 hydrochloride is promising for research of central nervous system disorders such as schizophrenia, Parkinson’s disease.

(R)-DRF053 is a CDK inhibitor. (R)-DRF053 inhibits Cdk5 and promotes the formation of ductal precursor β cells. (R)-DRF053 inhibits Dil-ox-LDL uptake and CD36 gene expression induced by advanced glycation end products (AGEs) in U937 cells.

(R)-6-Hydroxybuspirone is a metabolite of the anxiolytic agent Buspirone. (R)-6-Hydroxybuspirone itself also has anxiolytic activity.

(M)-AVI-4773 is an orally active, blood-brain barrier permeable coronaviruses MPro inhibitor with an IC50 of 2.5 nM aginst SARS-CoV-2 MPro. (M)-AVI-4773 produces a rapid onset antiviral effect in mouse models of MERS-CoV and SARS-CoV-2 infection.

(E)-RNB-61 is the E configuration of RNB-61. RNB-61 is an orally active cannabinoid CB2 receptor (CB2R) agonist with a Ki range of 0.13 nM to 1.81 nM. RNB-61 has renal protective and/or anti-fibrotic effects.

(E)-FOBISIN101 is a 14-3-3 protein-protein interaction (14-3-3 protein-protein interaction) inhibitor, with IC50 values of 9.3 and 16.4 μM for disrupting the binding of 14-3-3ζ or 14-3-3γ to PRAS40, respectively. (E)-FOBISIN101 inhibits the binding of 14-3-3 to Raf-1 and proline-rich AKT substrate, and neutralizes the ability of 14-3-3 to activate exotoxin S ADP-ribosyltransferase. (E)-FOBISIN101 is applicable to 14-3-3-mediated cancer research.